Abstract
Objectives To evaluate the results of the inoperable and operable with aortic valve endocarditis.
Methods This was a retrospective study of patients with aortic valve endocarditis undergoing cardiac surgery between January 2006 and November 2022 at our hospital.
Results 512 patients were divided into group with destruction of the aortic annulus (n=80) and without destruction of the aortic annulus (n=432). There were 32 operative deaths (6.3%, 32/512). Univariate and multivariate analysis showed that destruction of the aortic annulus is statistically significantly associated with in-hospital mortality (P<0.001), prolonged mechanical ventilation time (mechanical ventilation time> 96h, P=0.018), early aortic paravalvular leak (P<0.001), and 1-year mortality following cardiac surgery (P<0.001), respectively.
Conclusions In our study, destruction of the aortic annulus increases mortality and health care costs. Optimization of pre-, peri-, and postoperative factors can reduce mortality and morbidity in aortic valve endocarditis. Aortic root replacement could be recommended as the best practice choice for aortic valve endocarditis with periannular abscess and destruction of the aortic annulus.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
yes
Funding Statement
This work was supported by the Natural Science Foundation of China (No: 81360014), the Natural Science Foundation of Guangxi (No: 2014GXNSFAA118234), the Guangxi key scientific and technological project (No: 2013BC26236), and the Projects in Guangxi Health Department (No: GZPT13-27).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The experiment protocol for involving humans was approved by the Medical Ethics Committee of The People's Hospital of Guangxi Zhuang Autonomous Region.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
yes
